GRANT OF RESEARCH LICENSE. SPONSOR hereby grants WSU a nonexclusive, nontransferable, royalty-free license to use SPONSOR’S technology and SPONSOR Confidential Information solely for purposes of conducting the Program.
GRANT OF RESEARCH LICENSE. OGS hereby grants NeoGenesis a nonexclusive, nontransferable, royalty-free license to use OGS Know-How and OGS Patent Rights solely for the purposes of conducting the Program and performing NeoGenesis's obligations to OGS under the Program. NeoGenesis will not use OGS Know-How or OGS Patent Rights for any other purpose, without OGS's prior written permission. NeoGenesis shall not (a) grant, or attempt to grant, a sub-license to use OGS Know-How or OGS Patent Rights to any Person without the express written consent of OGS, (b) perform any tests on any of the Targets that are outside the scope of the Program, or (c) modify the Targets supplied by OGS, including, without limitation, the making of any derivatives, analogs or components thereof. In the event that NeoGenesis does not consume all quantities of the Targets supplied by OGS in performance of the Program, NeoGenesis will, upon completion of the Program promptly, return to OGS any quantities of such Target(s) and any derivatives, analogs or components thereof or destroy said quantities, at OGS's option.
GRANT OF RESEARCH LICENSE. CUSTOMER hereby grants NeoGenesis a nonexclusive, nontransferable, royalty-free license to use CUSTOMER Know-How and CUSTOMER Patent Rights solely for purposes of conducting the Program and performing NeoGenesis's obligations to CUSTOMER under the Program. NeoGenesis will not use CUSTOMER Know-How or CUSTOMER Patent Rights for any other purpose, without CUSTOMER's prior written permission. NeoGenesis shall not (a) grant, or attempt to grant, a sub-license to use CUSTOMER Know-How or CUSTOMER Patent Rights to any Person without the express written consent of CUSTOMER, (b) perform any tests on any of the Targets or using CUSTOMER assays or libraries that are outside the scope of the Program, or (c) modify the Targets supplied by CUSTOMER, including, without limitation, the making of any derivatives, analogs or components thereof. In the event that NeoGenesis does not consume all of the Targets, assays or libraries supplied by CUSTOMER in performance of the Program, NeoGenesis will upon completion of the Program promptly, return to CUSTOMER any quantities of such Target(s) and any derivatives, analogs or components thereof as well as assays and CUSTOMER supplied Samples related thereto.
GRANT OF RESEARCH LICENSE. Mitsubishi hereby grants NeoGenesis a nonexclusive, nontransferable, royalty-free license to use Mitsubishi Know-How and Mitsubishi Patent Rights solely for purposes of conducting the Program and performing NeoGenesis's obligations to Mitsubishi under the Program. NeoGenesis will not use Mitsubishi Know-How or Mitsubishi Patent Rights for any other purpose, without Mitsubishi's prior written permission. NeoGenesis shall not (a) grant, or attempt to grant, a sub-license to use Mitsubishi Know-How or Mitsubishi Patent Rights to any Person without the express written consent of Mitsubishi, (b) perform any tests on either of the Targets that are outside the scope of the Program, or (c) modify the Targets supplied by Mitsubishi, including, without limitation, the making of any derivatives, analogs or components thereof. In the event that NeoGenesis does not consume all of the Targets supplied by Mitsubishi in performance of the Program, NeoGenesis will upon completion of the Program promptly, return to Mitsubishi any quantities of such Target(s) and any derivatives, analogs or components thereof.
GRANT OF RESEARCH LICENSE. 16 8.1.2. Grant of Commercial License 16 8.1.3. Grant of License by Allergan 16 8.2. Reservation of Rights. 17 8.3. Manufacturing Rights. 17 8.3.1. Allergan's Right to Manufacture 17 8.3.2. Reservation of Rights 17 8.4. Marketing and Distribution Rights 17
GRANT OF RESEARCH LICENSE. CNSI hereby agrees to grant to Allergan the worldwide exclusive right and license in the Field under the CNSI Patent Rights, CNSI Technology, CNSI Inventions and CNSI's interest in Joint Patent Rights and Joint Inventions to the extent necessary or useful to carry out Allergan's research and development responsibilities under the Program in accordance with this Agreement, subject to Section 8.2 and Article 11 below. With respect to each Collaboration Compound or Active Compound selected as a Development Compound or Back-Up Compound by Allergan, the right and license granted pursuant to this Section shall continue and be supplemented by the license granted pursuant to Section 8.1.2 below for such compound.
GRANT OF RESEARCH LICENSE. Subject to the terms and conditions of this Agreement, Celltech hereby grants to NeoGenesis and NeoGenesis hereby accepts, a nonexclusive, nonsublicenseable; nontransferable, non-assignable, royalty-free license to Celltech Technology solely for purposes of performing NeoGenesis' obligations to Celltech under the Research Collaboration Plan during the Research Term. NeoGenesis shall not use Celltech Technology for any other purpose. NeoGenesis shall not (i) grant, or attempt to grant, a sub-license to Celltech Technology to any Person, (ii) perform any tests on any Approved Target(s) other than as part of the Research Collaboration Plan, or (iii) modify the Approved Targets supplied by Celltech, including, without limitation, the making of any derivatives, analogs or components thereof. In the event that NeoGenesis does not consume all of the Approved Target(s) supplied by Celltech in performance of the Research Collaboration Plan, NeoGenesis shall, upon Celltech's request, promptly return to Celltech any remaining quantities of such Approved Target(s).
GRANT OF RESEARCH LICENSE. 4.1 ZBB hereby grants HONAM a worldwide, non-exclusive, non-transferable (except as provided herein below), license and right (without the right to grant sublicenses) to use ZBB’s Background Technology, together with a non-exclusive, non-transferable (except as provided herein below), license and right (without the right to grant sublicenses) under Patent Rights in ZBB Improvements developed or acquired prior to the termination date, both licenses solely for HONAM’ internal research in the Field. This license and right is extendable to Affiliates of HONAM only.
GRANT OF RESEARCH LICENSE. During the Research Term, Syngenta hereby grants to Diversa a non-exclusive, royalty-free license under Syngenta Proprietary Technology and any Patent Rights and Know-How Controlled by Syngenta and its Affiliates which Syngenta determines should be used in any Syngenta Project (including any such rights exclusively licensed to Syngenta by Diversa hereunder) to use in connection with the conduct of any Syngenta Project in the Syngenta Exclusive Field. If Syngenta elects to provide Diversa with access to its genomics data for such purpose, Diversa acknowledges and agrees that it shall use such genomics data solely for its research under any Syngenta Project in the Syngenta Exclusive Field and, if applicable, any other Syngenta Projects conducted by Diversa for Syngenta under any Syngenta Project, and for no other purpose. This license is personal to Diversa and does not include a right to sublicense or a right to commercialize.
GRANT OF RESEARCH LICENSE. In addition to the reserved license of Paragraph 3 above in this Appendix C, PHS reserves the right to grant nonexclusive Research Licenses directly or to require KSA to grant nonexclusive Research Licenses on reasonable terms. The purpose of this Research License is to encourage basic research, whether conducted at an academic or corporate facility, but in no event shall the Research License be used for any commercial purpose. Additionally and in order to safeguard the Licensed Patent Rights, however, PHS will consult with KSA before granting to commercial entities a Research License or providing to them research samples of materials made through the Licensed Processes.
